World Health Assembly, May 2001 Statements May 21, 2001. Health GAP Report on the 54th World Health Assembly. May 18, 2001. CPT/Essential Action Comments on the World Health Assembly. May 17, 2001. HealthGAP Coalition Release on the World Health Assembly.… Continue Reading →
2018 Seventy-first World Health Assembly (WHA 71) 142nd WHO Executive Board Meeting (EB 142) 2017 Seventieth World Health Assembly (WHA 70) 2016 Sixty-ninth World Health Assembly (WHA 69) 2015 WHA 68 2014 WHA 67 2013 WHA 66 2012 WHA 65… Continue Reading →
KEI page on Research and Development Cost Transparency Legislation EB142: KEI statement on Addressing the global shortage of, and access to, medicines and vaccines, January 24th, 2018 Expert Panel charts a road map for WHO’s engagement on transparency and R&D,… Continue Reading →
On Tuesday, 27 February 2018, the representative of the Republic of South Africa delivered the following statement at the World Trade Organization’s TRIPS Council; South Africa delivered this statement under the agenda item on IP and the Public Interest: Regulatory… Continue Reading →
KEI has appealed the NIH/NCI decision to proceed with the proposed exclusive license of anti-CD30 CAR T to Gilead, following an email of January 25, 2018 from Dr. David Lambertson of NCI rejecting all of KEI’s substantive suggestions and objections. KEI… Continue Reading →
December 12 to December 15, 2016 WIPO’s Page on the Meeting SCP 25: Opening statement of Knowledge Ecology International SCP25: Statement of Asia Pacific Group on Patents and Health SCP25: South Africa’s Experience Related to the Topic of Access to… Continue Reading →
December 11 to December 15, 2017 WIPO’s Page for the Meeting SCP27: WIPO patent committee agrees to future work on patent oppositions, exceptions and limitations, and patents and health SCP27: South Africa urges WIPO to invite UNHLP Co-Chairs to present… Continue Reading →
KEI page on the World Trade Organization’s (WTO) Trade Policy Reviews All members of the WTO are subject to review under the Trade Policy Review Mechanism (TPRM). The TPRM takes place in the “Trade Policy Review Body which is actually… Continue Reading →
Representative Ro Khanna (D-CA-17) was joined by 17 other members of Congress in calling upon Department of Health and Human Services Secretary Alex Azar to issue a compulsory license on patents for medications to treat hepatitis C, by exercising 28… Continue Reading →